These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35300306)

  • 21. Predicting Solubility of Newly-Approved Drugs (2016-2020) with a Simple ABSOLV and GSE(
    Avdeef A; Kansy M
    J Solution Chem; 2022; 51(9):1020-1055. PubMed ID: 35153342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.
    Doak BC; Over B; Giordanetto F; Kihlberg J
    Chem Biol; 2014 Sep; 21(9):1115-42. PubMed ID: 25237858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A story of peptides, lipophilicity and chromatography - back and forth in time.
    Erckes V; Steuer C
    RSC Med Chem; 2022 Jun; 13(6):676-687. PubMed ID: 35800203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational prediction of formulation strategies for beyond-rule-of-5 compounds.
    Bergström CAS; Charman WN; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():6-21. PubMed ID: 26928657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are we ready to design oral PROTACs®?
    Jimenez DG; Sebastiano MR; Caron G; Ermondi G
    ADMET DMPK; 2021; 9(4):243-254. PubMed ID: 35300370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling the Chameleonic Behavior and Membrane Permeability of Cyclosporine Derivatives via Backbone and Side Chain Modifications.
    Lee D; Choi J; Yang MJ; Park CJ; Seo J
    J Med Chem; 2023 Sep; 66(18):13189-13204. PubMed ID: 37718494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets.
    Doak BC; Zheng J; Dobritzsch D; Kihlberg J
    J Med Chem; 2016 Mar; 59(6):2312-27. PubMed ID: 26457449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.
    DeGoey DA; Chen HJ; Cox PB; Wendt MD
    J Med Chem; 2018 Apr; 61(7):2636-2651. PubMed ID: 28926247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permeability prediction in the beyond-Rule-of 5 chemical space: Focus on cyclic hexapeptides.
    Digiesi V; de la Oliva Roque V; Vallaro M; Caron G; Ermondi G
    Eur J Pharm Biopharm; 2021 Aug; 165():259-270. PubMed ID: 34038796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro toolbox to accelerate anti-malarial drug discovery and development.
    Charman SA; Andreu A; Barker H; Blundell S; Campbell A; Campbell M; Chen G; Chiu FCK; Crighton E; Katneni K; Morizzi J; Patil R; Pham T; Ryan E; Saunders J; Shackleford DM; White KL; Almond L; Dickins M; Smith DA; Moehrle JJ; Burrows JN; Abla N
    Malar J; 2020 Jan; 19(1):1. PubMed ID: 31898492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partition coefficient and molecular flexibility: the concept of lipophilicity space.
    Vistoli G; Pedretti A; Testa B
    Chem Biodivers; 2009 Aug; 6(8):1152-69. PubMed ID: 19697333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design Principles for Intestinal Permeability of Cyclic Peptides.
    Mathiowetz AM
    Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Trends in Macrocyclic Drug Discovery and beyond-Ro5.
    Alihodžić S; Bukvić M; Elenkov IJ; Hutinec A; Koštrun S; Pešić D; Saxty G; Tomašković L; Žiher D
    Prog Med Chem; 2018; 57(1):113-233. PubMed ID: 29680148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral Drugs.
    Ermondi G; Garcia Jimenez D; Rossi Sebastiano M; Caron G
    ACS Med Chem Lett; 2021 Jul; 12(7):1056-1060. PubMed ID: 34262642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges.
    Edmondson SD; Yang B; Fallan C
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1555-1564. PubMed ID: 31047748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular inflation, attrition and the rule of five.
    Leeson PD
    Adv Drug Deliv Rev; 2016 Jun; 101():22-33. PubMed ID: 26836397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of drug solubility from molecular structure using a drug-like training set.
    Huuskonen J; Livingstone DJ; Manallack DT
    SAR QSAR Environ Res; 2008; 19(3-4):191-212. PubMed ID: 18484495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the Permeability of Macrocycles from Conformational Sampling - Limitations of Molecular Flexibility.
    Poongavanam V; Atilaw Y; Ye S; Wieske LHE; Erdelyi M; Ermondi G; Caron G; Kihlberg J
    J Pharm Sci; 2021 Jan; 110(1):301-313. PubMed ID: 33129836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout Rats.
    Miyake T
    Biol Pharm Bull; 2020 Mar; 43(3):384-392. PubMed ID: 31685755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.